TREK-1 is a novel molecular target in prostate cancer.
Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C, Feinmark SJ.
Voloshyna I, et al. Among authors: besana a.
Cancer Res. 2008 Feb 15;68(4):1197-203. doi: 10.1158/0008-5472.CAN-07-5163.
Cancer Res. 2008.
PMID: 18281496